Zobrazeno 1 - 10
of 181
pro vyhledávání: '"S. Kopprasch"'
Autor:
I, Ansurudeen, S, Kopprasch, M, Ehrhart-Bornstein, H S, Willenberg, A W, Krug, R H, Funk, R H W, Funk, S R, Bornstein
Publikováno v:
Hormone and Metabolic Research. 38:476-480
Alterations in both vasculature and renin-angiotensin-aldoster-one system are a consistent finding in the metabolic syndrome. Adrenal tissue is highly vascularized and encounters blood flow, exceeding by far the volume expected for its size. Endothel
Autor:
Mathias Forkmann, Anne-Kathrin Tausche, Martin Aringer, Carsten Wunderlich, C. Bielitz, S. Kopprasch, U. Richter, Marian Christoph
Publikováno v:
Rheumatology international. 34(1)
We prospectively evaluated whether an effective 12-month uric acid-lowering therapy (ULT) with the available xanthine oxidase (XO) inhibitors allopurinol and febuxostat in patients with chronic tophaceous gout has an impact on oxidative stress and/or
Publikováno v:
Pediatric Surgery International. 9:297-300
Lyell's syndrome (LS) (toxic epidermal necrolysis) is also known as “scalded skin syndrome.” When caused by staphylococci, it has a favorable prognosis. However, as a drug reaction, primarily to sulfonamides, anticonvulsives, and antirheumatic ag
Publikováno v:
Diabetologie und Stoffwechsel. 4
Publikováno v:
Analytica Chimica Acta. 255:373-381
The formation of reactive O 2 species in the pancreas of pigs after induction of necrotizing or oedematous pancreatitis was studied by means of luminol- and lucigenim-sensitized chemiluminescence. The effect of 2,2-dimethyl-4-methanesulphonic acid-1,
Publikováno v:
Zeitschrift fur Rheumatologie. 66(7)
In highly industrialized countries hyperuricemia is one of the most common metabolic disorders. High uric acid blood levels may lead to the manifestation of gout owing to the precipitation of urate crystals in connective tissue, the skeletal system a
Publikováno v:
Zeitschrift fur Rheumatologie. 63(4)
The antiphospholipid syndrome (APS) with its typical clinical manifestations of recurrent thrombosis and fetal loss is biochemically defined by the presence of circulating antiphospholipid antibodies (aPL). The disease pattern has raised special inte
Autor:
J, Graessler, F, Spitzenberger, A, Graessler, B, Parpart, E, Kuhlisch, S, Kopprasch, H E, Schroeder
Publikováno v:
Advances in experimental medicine and biology. 486
Publikováno v:
Bioluminescence and Chemiluminescence.
Publikováno v:
Journal of clinical apheresis. 15(4)
Hypercholesterolemia and oxidative stress are major risk factors in atherogenesis. In the last years, lipid apheresis has been established as an effective clinical therapy by lowering not only elevated plasma low-density lipoprotein (LDL) levels but